Ceftolozane, tazobactam drug combination
Showing 1 - 25 of >10,000
Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa
Active, not recruiting
- Antibiotic Resistant Strain
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Mar 30, 2022
Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)
Not yet recruiting
- Bronchiectasis
- +3 more
- (no location specified)
Sep 6, 2023
Complicated Intra-abdominal Infections Trial in China (Ceftolozane/Tazobactam, Metronidazole, Meropenem)
Completed
- Complicated Intra-abdominal Infections
- Ceftolozane/Tazobactam
- +3 more
-
Hefei, Anhui, China
- +24 more
Jan 13, 2023
Ventilator-associated Pneumonia Trial in Toulouse (1 hour infusion, 4 hours infusion)
Recruiting
- Ventilator-associated Pneumonia
- 1 hour infusion
- 4 hours infusion
-
Toulouse, FranceService Réanimation Polyvalente - CHU Rangueil
Jun 8, 2022
Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)
Withdrawn
- Bacteremia Caused by Gram-Negative Bacteria
-
Newcastle, New South Wales, Australia
- +28 more
May 17, 2022
Nosocomial Infections in Patients With ARDS Treated With ECMO
Not yet recruiting
- Acute Respiratory Distress Syndrome
- +2 more
- Collection of blood and bronchoalveolar samples to study Pharmacokinetics of ceftazidime/avibactam, meropenem/varbobactam, ceftolozane/tazobactam, or cefiderocol
-
Milan, ItalyFondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Sep 30, 2022
Pseudomonas Aeruginosa, Pneumonia, Hematologic Malignancy Trial in New York (Ceftolozane / Tazobactam Injection)
Suspended
- Pseudomonas Aeruginosa
- +2 more
- Ceftolozane / Tazobactam Injection
-
New York, New YorkWeill Cornell Medicine
Jan 25, 2022
Neutropenia, Febrile, Hematologic Cancer Trial in Doha (Ceftolozane-tazobactam IV)
Not yet recruiting
- Neutropenia, Febrile
- Hematologic Cancer
- Ceftolozane-tazobactam IV
-
Doha, QatarHamad Medical Corporation, National Center for Cancer Care and R
Apr 7, 2022
Perforated Appendicitis, Postoperative Infection Trial in Phoenix, Kansas City (Piperacillin, Tazobactam Drug Combination)
Active, not recruiting
- Perforated Appendicitis
- Postoperative Infection
- Piperacillin, Tazobactam Drug Combination
-
Phoenix, Arizona
- +1 more
Apr 22, 2022
Respiratory Infections Due to Extensively Drug-resistant
Unknown status
- Ventilator Associated Pneumonia
- Antibiotic Resistant Infection
-
Budapest, HungarySemmelweis University
Apr 15, 2020
Complicated Urinary Tract Infection, Pyelonephritis Trial in Worldwide (Ceftolozane/Tazobactam, Meropenem)
Completed
- Complicated Urinary Tract Infection
- Pyelonephritis
-
Los Angeles, California
- +51 more
Nov 3, 2021
Burns, Pharmacokinetics Trial in Lubbock (Ceftolozane/tazobactam)
Terminated
- Burns
- Pharmacokinetics
-
Lubbock, TexasUniversity Medical Center
Mar 1, 2021
Pharmacokinetics Trial in Brisbane (Ceftolozane/tazobactam)
Completed
- Pharmacokinetics
-
Brisbane, Queensland, AustraliaRoyal Brisbane and Women's Hospital
Aug 21, 2020
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation, Pseudomonas Aeruginosa Infection Trial in United States
Completed
- Cystic Fibrosis
- +2 more
-
Hartford, Connecticut
- +3 more
Jul 27, 2020
Antibiotic Plasma Concentrations During Continuous Renal
Recruiting
- Hemodiafiltration
- +2 more
- Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®)
- Antibiotics
-
Barcelona, SpainHelena Colom Codina
Sep 1, 2021
Infections Trial in Ghent (device, diagnostic test, other)
Not yet recruiting
- Infections
- Prediction of plasma concentration of piperacillin-tazobactam or meropenem
- +2 more
-
Ghent, BelgiumUniversity Hospital, Ghent
Sep 4, 2023
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Canada, Israel
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
-
Montreal, Quebec, Canada
- +7 more
Jul 25, 2022
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Israel (Piperacillin / Tazobactam
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
- Piperacillin / Tazobactam Injection
- Meropenem
-
Haifa, Israel
- +3 more
Jul 25, 2022
Pancreaticoduodenectomy, Antibiotherapy Trial (Antibioprophylaxis (Piperacillin-tazobactam), 5 days Antibiotherapy
Not yet recruiting
- Pancreaticoduodenectomy
- Antibiotherapy
- Antibioprophylaxis (Piperacillin-tazobactam)
- 5 days Antibiotherapy (Piperacillin-tazobactam)
- (no location specified)
Nov 3, 2023
Ceftolozane-Tazobactam Plasmatic Levels in Critical Patients
Unknown status
- Serious Infection
-
Sevilla, SpainHospital Universitario Virgen Macarena
Feb 5, 2020
Pancreatic Cancer, Pancreas Cancer, Pancreatic Diseases Trial in Canada, United States (Cefoxitin, Piperacillin-tazobactam)
Active, not recruiting
- Pancreatic Cancer
- +2 more
-
Sacramento, California
- +31 more
Jan 12, 2023
Appendicitis Perforated Trial (Piperacillin/tazobactam, Normal saline, CefTRIAXone Injection)
Not yet recruiting
- Appendicitis Perforated
- Piperacillin/tazobactam
- +3 more
- (no location specified)
Jul 4, 2023
Cystic Fibrosis Trial in Morgantown (Piperacillin-tazobactam combination product)
Terminated
- Cystic Fibrosis
- Piperacillin-tazobactam combination product
-
Morgantown, West VirginiaWest Virginia University Healthcare
Jan 28, 2022
Use of New Antibiotics in Sweden
Recruiting
- Multi-antibiotic Resistance
-
Gothenburg, Sweden
- +6 more
Feb 11, 2022